全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Malaria Characteristics in Children with Sickle Cell Disease

DOI: 10.4236/ojped.2022.121013, PP. 125-130

Keywords: Malaria, Sickle Cell Disease, Children

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: The relationship between sickle cell disease and malaria is the subject of much controversy. However, there is a lack of data in our services. Our objective was to study the epidemiological, diagnostic and evolutionary characteristics of malaria in children with sickle cell disease followed in a specialized setting. Patients and Methods: We conducted a retrospective, descriptive, and analytical study of children with sickle cell disease (SCD) who presented with malaria and were followed at the Ambulatory Care Unit for Sickle Cell Children and Adolescents (USAD) at the Albert Royer National Children’s Hospital in Dakar, from January 1st, 2017, to December 31th, 2019. We included all the followed pediatric patients, less than 16 years, with sickle cell disease who presented at least one episode of malaria, confirmed by a positive thick drop, during this 3 years. We did not include patients with incomplete records or those older than 16 years. The clinical and biological signs, the follow up was collected and analyzed with Excel package 2019. Results: Of 3773 patients followed for sickle cell disease, 21 had presented malaria. The frequency was 0.5% or 7 cases/year. However, we exploited the data of 14 of them. The sex ratio was 6 boys for a girl and the mean age at admission was 7.3 years. The highest number of malaria cases was observed in 2018 and the peak frequency was observed in November with 8 cases (57.1%). Fever was the most frequent symptom, observed in 10 patients (71.4%). All patients were SS homozygous, with a mean baseline hemoglobin level of 7.5g/dl. All patients had a positive thick blood smear and Plasmodium falciparum was the only species found in the blood smear, with a mean parasite density of 1693 parasites/ml of blood. All patients had anemia, with a mean hemoglobin level of 7.74 g/dl. Twelve patients (85.7%) were hospitalized and had all received injectable

References

[1]  Sangare, A., Sanogo, I., Ebongo, E., Meite, M., Faget, P.K., Sawadogo, S., et al. (1990) Contribution à l’étude des relations entre la drépanocytose et le paludisme. Medecine d’Afrique Noire, 37, 268-273.
[2]  Diagne, I., Ndiaye, O., Moreira, C., Sy, H.S., Camara, B., Diouf, S., et al. (2000) Les syndromes drépanocytaires majeurs en pédiatrie à Dakar (Sénégal). Archives of Pediatrics, 7, 16-24.
https://doi.org/10.1016/S0929-693X(00)88912-5
[3]  Aloni, N.M., Tshimanga, B.K., Ekulu, P.M., Ehungu, J.L. and Ngiyulu, R.M. (2013) Malaria, Clinical Features and Acute Crisis in Children with Sickle Cell Disease in Resource-Constrained Countries: Retrospective Description of 90 Cases. Pathogens and Global Health, 107, 198-201.
https://doi.org/10.1179/2047773213Y.0000000089
[4]  Ngo Linwa, E., Cumber, S.N., Eposse, E.C., Esuh, E.L., Mandeng, M.L., Nkfusai, C.N., et al. (2020) Malaria in Patients with Sickle Cell Anaemia: Burden, Risk Factors and Outcome at the Laquintinie Hospital, Cameroon. BMC Infectious Diseases, 20, Article No. 40.
https://doi.org/10.1186/s12879-019-4757-x
[5]  Diop, S., Soudre, F., Seck, M., Guèye, Y.B., Dieye, T.N., Fall, A.O., et al. (2011) Sickle-Cell Disease and Malaria: Evaluation of Seasonal Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine in Senegalese Patients—A Randomized Placebo-Controlled Trial. Annals of Hematology, 90, 23-27.
https://doi.org/10.1007/s00277-010-1040-z
[6]  Komba, A.N., Makani, J., Sadarangani, M., Ajala-Agbo, T., Berkley, A.J., Charles, R.J., et al. (2009) Malaria as a Cause of Morbidity and Mortality in Children with Homozygous Sickle Cell Disease on the Coast of Kenya. Clinical Infectious Diseases, 49, 216-222.
https://doi.org/10.1086/599834
[7]  Williams, T.N., Mwangi, T.W., Wambua, S., Alexander, N.D., Kortok, M., Snow, R.W., et al. (2005) Sickle Cell Trait and the Risk of Plasmodium falciparum Malaria and Other Childhood Diseases. The Journal of Infectious Diseases, 192, 178-186.
https://doi.org/10.1086/430744
[8]  Pasvol, G., Weatherall, D.J. and Wilson, R.J. (1978) Cellular Mechanism for the Protective Effect of Haemoglobin S against P. falciparum Malaria. Nature, 274, 701-703.
https://doi.org/10.1038/274701a0
[9]  Haldane, J.B. (1949) The Rate of Mutation of Human Genes. Proceedings 8th International Congress on Genetics and Bered, Vol. 35, 267-273.
https://doi.org/10.1111/j.1601-5223.1949.tb03339.x
[10]  Makani, J., Komba, A.N., Cox, S.E., Oruo, J., Mwamtemi, K., Kitundu, J., et al. (2020) Malaria in Patients with Sickle Cell Anemia: Burden, Risk Factors, and Outcome at the Outpatient Clinic and during Hospitalization. BMC Infectious Diseases, 20, Article No. 40.
[11]  Warley, M.A., Hamilton, P.J., Marsden, P.D., Brown, R.E., Merselis, J.G. and Wilks, N. (1965) Chemoprophylaxis of Homozygous Sicklers with Antimalarials and Long-Acting Penicillin. British Medical Journal, 2, 86.
https://doi.org/10.1136/bmj.2.5453.86
[12]  Powars, D.R. (1991) Sickle Cell Anemia: Beta s-Gene-Cluster Haplotypes as Pronostic Indicators of Vital Organ Failure. Seminars in Hematology, 28, 202-208.
[13]  Oniyangi, O. and Omari, A.A. (2006) Malaria Chemoprophylaxis in Sickle Cell Disease. Cochrane Database of Systematic Reviews, No. 4, CD003489.
https://doi.org/10.1002/14651858.CD003489.pub2
[14]  Diagne, I., Gueye, N.D., Sy, H.S., Camara, B., Sall, P.L., Sarr, M., et al. (2003) Prise en charge de la drépanocytose chez l’enfant en Afrique: Experience de la cohorte de l’hôpital d’enfants Albert Royer de Dakar. Medecine Tropicale, 63, 513-520.
[15]  Luzzatto, L. (2012) Sickle Cell Anaemia and Malaria. Mediterranean Journal of Hematology and Infectious Diseases, 4, e2012065.
https://doi.org/10.4084/mjhid.2012.065

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133